Search Results for agency_names:"Justice Department"

Globyz Pharma, LLC has applied to the Drug Enforcement Administration (DEA) for registration as an importer of controlled substances for analytical testing. The application does not authorize any other activities, such as importing FDA-approved finished dosage forms for sale. Interested parties, including registered manufacturers, can submit comments or objections, or request a hearing regarding this application by March 26, 2021. The DEA's decision will be based on alignment with legal requirements under 21 U.S.C. 952(a)(2).

The Drug Enforcement Administration (DEA) has revoked Rachel Jackson's DEA Certificate of Registration because she is not licensed to handle controlled substances in Maine. Jackson voluntarily surrendered her Maine physician assistant license, making her ineligible to practice or register with the DEA. Despite being alerted about the situation and the chance to request a hearing, Jackson did not respond, leading to a default determination and subsequent action to revoke her registration. The order for revocation is effective from April 21, 2025.

The Drug Enforcement Administration (DEA) has announced that North Star Holdings California, LLC, has applied to become a registered bulk manufacturer of marihuana, a Schedule I controlled substance. This application is part of a DEA program that regulates the cultivation of marihuana for scientific and medical research purposes. The DEA will review this and similar applications to ensure compliance with relevant laws and regulations, ensuring that adequate measures are in place to prevent illegal distribution. Interested parties may submit comments or objections to the DEA regarding this application before April 19, 2021.

The Department of Justice's Drug Enforcement Administration (DEA) is seeking public comments on a new information collection proposal. They aim to revise existing forms (DEA Forms 224 and 224A) to include emergency medical services (EMS) agencies under the Controlled Substances Act. This change would allow EMS agencies to register to handle controlled substances in line with state law. The comment period is open for 30 days, during which people can share their thoughts on the proposal's necessity, accuracy, and possible burden on those required to respond.

The Drug Enforcement Administration (DEA) revoked the registration of Hazem Barmada, M.D., allowing him to handle controlled substances in Mississippi because he no longer has a valid medical license in the state. The Mississippi State Board of Medical Licensure had accepted his voluntary surrender of the license in 2021, making him ineligible to practice medicine and handle controlled substances there. As holding a valid state license is necessary for DEA registration, Dr. Barmada’s registration was revoked, and any pending applications related to it were denied. This decision will take effect on April 21, 2025.

UHD Alliance, Inc. submitted notifications to the Attorney General and Federal Trade Commission on December 10, 2020, about changes in its membership under the National Cooperative Research and Production Act of 1993. The changes include adding Fengmi (Beijing) Technology Co., Ltd. from China as a new member, while Charter Communications, Technicolor SA, and Westinghouse Electronics have left the group. The purpose of these notifications is to ensure that the group’s antitrust protections continue, limiting the recovery of damages by antitrust plaintiffs. The group remains open to new members and will continue to update the authorities on any further changes in membership.

The Drug Enforcement Administration (DEA) has revoked the DEA registration of Xubex Community Pharmacy in Casselberry, Florida. This decision was made because the pharmacy dispensed controlled substances, specifically Schedule II drugs like oxycodone and hydromorphone, without prescriptions. The DEA considered these actions a threat to public health and safety, demonstrating that the pharmacy cannot be trusted to comply with legal requirements. Furthermore, the pharmacy did not request a hearing to dispute these conclusions, leading to the default revocation of its registration.

The Bureau of Prisons within the Justice Department has issued a supplemental notice proposing updates to the Inmate Financial Responsibility Program. This program helps inmates manage and pay off financial obligations like court fees and child support while they are incarcerated. The proposal includes changes such as encouraging inmates to pay a portion of outside deposits towards their financial responsibilities, while also prioritizing family support obligations. Public comments on these proposed updates are welcomed until February 18, 2025.

The Department of Justice (DOJ) is seeking public comments for a period of 60 days, ending on April 27, 2021, regarding an information collection under the Radiation Exposure Compensation Act. This proposed extension of a currently approved collection aims to gather data to determine eligibility for compensation. The collection targets individuals or households, requiring an estimated 2.5 hours per respondent, with a total expected annual burden of 5,000 hours. Feedback on the necessity, accuracy, quality, and burden minimization of the collection is requested to enhance its utility and efficiency.

The Department of Justice, through its Criminal Division, is requesting public comments on the renewal of an information collection under the Gambling Devices Act of 1962. This request involves the registration of entities involved in the interstate commerce of gambling devices and is aimed at collecting specific information from respondents. The proposed renewal, requiring response from approximately 7,800 individuals annually, takes roughly 5 minutes per submission. Comments are being accepted for 30 days until February 12, 2025, and are encouraged to focus on aspects such as the necessity, accuracy, and methodology of the information collection.